Role and management of extracorporeal life support after surgery of chronic thromboembolic pulmonary hypertension

被引:13
|
作者
Martin-Suarez, Sofia [1 ]
Gliozzi, Gregorio [1 ]
Fiorentino, Mariafrancesca [1 ]
Loforte, Antonio [1 ]
Ghigi, Valentina [2 ]
Di Camillo, Marcello [3 ]
Galie, Nazareno [4 ]
Pacini, Davide [1 ]
机构
[1] Bologna Univ, St Orsola Hosp, Cardiac Surg Dept, Padiglione CTV 23,Via Massarenti,9 CAP, I-40138 Bologna, Italy
[2] Bologna Univ, St Orsola Hosp, Cardiac Surg Anesthesia Dept, Bologna, Italy
[3] Bologna Univ, St Orsola Hosp, Bologna, Italy
[4] Bologna Univ, St Orsola Hosp, Cardiol Dept, Pulm Hypertens Unit, Bologna, Italy
关键词
Extracorporeal membrane oxygenator (ECMO); pulmonary endarterectomy (PEA); deep hypothermic arrest; pulmonary hypertension (PH); MEMBRANE-OXYGENATION; ENDARTERECTOMY; HEMORRHAGE; VENTRICLE; FAILURE; INDEX;
D O I
10.21037/acs.2019.01.02
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary endarterectomy (PEA) is a surgical intervention reserved for patients with chronic thromboembolic pulmonary hypertension (CTEPH). In some cases, temporary circulatory support [extracorporeal life support (ECLS)] is required after PEA. Rates of ECLS requirement varies between centers. Reasons for institution of ECLS include respiratory failure, cardiac failure (or both respiratory and cardiac failure), bleeding, and reperfusion edema. This article reviews the experience of ECLS after PEA from the current literature, as well as our own institution's experience as a CTEPH multidisciplinary center. Methods: A literature review was conducted along with a retrospective chart review from 15 years of our PEA program. Results: The literature demonstrates many different approaches are used for mechanically supporting patients who develop complications after PEA. Variations in approach stem from differing indications such as, respiratory failure rather than hemodynamic compromise (or vice versa), time of implantation (immediately in operating room or delayed after surgery) and many other causes. In our center, 12.3% (19/154) of patients need ECLS with extracorporeal membrane oxygenator (ECMO) after PEA procedure. Implantation was mainly in the operating room before or immediately after weaning from cardiopulmonary bypass and mostly peripheral cannulation was used. ECMO lasted an average of 11 +/- 8 days. And 52.6% (10 of 19 patients) of patients were weaned from ECLS and of this, 70% (7 of 10 patients) were discharged. Conclusions: In some cases of PEA, ECLS is needed post-operatively. Expert teams should consider this possibility pre-operatively based on predisposing characteristics. The need for ECMO shouldn't be "di per se" a contraindication to surgery but might be considered in the surgical risk estimation. The ideal setup is not fixed and depends on the center's practices as well as indication. Even though complications do occur with ECMO, in general, results are good, being a bridge to further recovery of pulmonary hypertension (PH) or also to transplantation.
引用
收藏
页码:84 / 92
页数:9
相关论文
共 50 条
  • [21] An Update on the Management of Chronic Thromboembolic Pulmonary Hypertension
    Edward, Justin A.
    Mandras, Stacy
    CURRENT PROBLEMS IN CARDIOLOGY, 2017, 42 (01) : 7 - 38
  • [22] RIOCIGUAT FOR THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
    Larche, N. E.
    Mousa, S. A.
    DRUGS OF TODAY, 2013, 49 (12) : 761 - 768
  • [23] Characteristics and Early Outcomes of Patients Requiring Extra Corporeal Life Support after Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension
    Boulate, D.
    Mercier, O.
    Fadel, E.
    Mussot, S.
    Fabre, D.
    Stephan, F.
    Dartevelle, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S213 - S214
  • [24] Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to and Support for Pulmonary Thromboendarterectomy in Misdiagnosed Chronic Thromboembolic Pulmonary Hypertension
    Faggian, Giuseppe
    Onorati, Francesco
    Chiominto, Bartolomeo
    Gottin, Leonardo
    Dan, Maurizio
    Ribichini, Flavio
    Menon, Tiziano
    Santini, Francesco
    Mazzucco, Alessandro
    ARTIFICIAL ORGANS, 2011, 35 (10) : 956 - U77
  • [25] The Role of Lung Ventilation/Perfusion Scan in the Management of Chronic Thromboembolic Pulmonary Hypertension
    Ha, Sejin
    Han, Sangwon
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 58 (07) : 449 - 458
  • [26] PULMONARY BLOOD-FLOW STEAL AFTER SURGERY FOR CHRONIC THROMBOEMBOLIC PULMONARY-HYPERTENSION
    OLMAN, MA
    AUGER, WR
    ASHBURN, WL
    HARTMAN, MT
    MOSER, KM
    CLINICAL RESEARCH, 1989, 37 (01): : A146 - A146
  • [27] Balloon Pulmonary Angioplasty in the Management of Chronic Thromboembolic Pulmonary Hypertension
    Higuchi, Satoshi
    Horinouchi, Hiroki
    Aoki, Tatsuo
    Nishii, Tatsuya
    Ota, Yasutoshi
    Ueda, Jin
    Tsuji, Akihiro
    Ota, Hideki
    Ogo, Takeshi
    Fukuda, Tetsuya
    RADIOGRAPHICS, 2022, 42 (06) : 1881 - 1896
  • [28] Role of Surgical and Medical Management of Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review
    Crowley, Alexandra V.
    Banfield, Megan
    Gupta, Aditi
    Raj, Rhea
    Gorantla, Vasavi R.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [29] Quality of life in patients with chronic thromboembolic pulmonary hypertension
    Mathai, Stephen C.
    Ghofrani, Hossein-Ardeschir
    Mayer, Eckhard
    Pepke-Zaba, Joanna
    Nikkho, Sylvia
    Simonneau, Gerald
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (02) : 526 - 537
  • [30] Chronic Thromboembolic Pulmonary Disease and Chronic Thromboembolic Pulmonary Hypertension
    Remy-Jardin, Martine
    Hutt, Antoine
    Remy, Jacques
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 43 (06) : 936 - 945